| ¿µ¹® | obesity | ÇÑ±Û | ºñ¸¸Áõ |
|---|---|---|---|
| ¼³¸í | ½Åü¿¡ Áö¹æÀÌ °úÀ×À¸·Î ÃàÀûµÇ¾î °ñ°Ý»ó ¹× À°Ã¼»ó ¿ä±¸ÀÇ ÇѰè ÀÌ»óÀ¸·Î üÁßÀÌ Áõ°¡µÈ »óÅÂÀÌ´Ù. ±×·¯³ª üÁö¹æÀÇ ÃøÁ¤Àº ½±Áö ¾Ê±â ¶§¹®¿¡ ¼öºÐ·ù³ª ±ÙÀ°Áõ°¡ÀÇ °æ¿ì¸¦ »©°í, ÀϹÝÀûÀ¸·Î´Â üÁßÁõ°¡¿Í µ¿ÀǾî·Î »ý°¢µÇ¾î Ç¥ÁØÃ¼Áß(ÀÌ»óüÁß)À» 10~20% ³Ñ´Â °æ¿ì¸¦ ºñ¸¸À̶ó Á¤ÀÇÇÑ´Ù. Èí¼ö Ä®·Î¸®°¡ ¼Òºñ Ä®·Î¸®¸¦ ³ÑÀ» ¶§´Â ±× Â÷¸¦ Áß¼ºÁö¹æÀ¸·Î ÇØ¼ Áö¹æ¼¼Æ÷¿¡ ÃàÀûµÇ¾îÁö´Â °á°ú üÁö¹æÀÌ Áõ°¡ÇÑ´Ù. Äí½ÌÁõÈıº, ½Ã»óÇϺμջó µî¿¡µµ ºñ¸¸ÀÌ ³ªÅ¸³´Ù. ºñ¸¸, ƯÈ÷ º¹ºÎ ºñ¸¸Àº ¿©·¯ Áúȯ, ƯÈ÷ ¼ºÀκ´À̶ó°í ÇÏ´Â ÁúȯÀÇ ¹ß»ý°ú °ü·ÃÀÌ ÀÖ´Â °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ºñ¸¸µµÀÇ Æò°¡¿¡´Â üÁßÀ» ÃøÁ¤ÇÏ´Â ¹æ¹ý, ÇǺÎÁÖ¸§µÎ²² ÃøÁ¤¹ý(͏®ÆÛ¸¦ »ç¿ë)ÀÌ ÀÖ´Ù. ºñ¸¸µµ Áö¼ö¸¦ Æò°¡ÇÏ´Â ÀÓ»óÀûÀÎ ¹æ¹ý¿¡´Â ÀÌ»óüÁß¹ý(modified Broca's method)À¸·Î °¡Àå ½±°Ô »ç¿ëÇÏ´Â ¹æ¹ýÀ̸ç [½ÅÀå(cm)£100]¡¿0.9¸¦ ÀÌ»óüÁßÀ¸·Î °è»êÇÏ¿© ÇöÀçüÁßÀ» ¹éºÐÀ²È½ÃŲ ¹æ¹ýÀÌ´Ù. ºñ¸¸µµ = (½ÇÃøÃ¼ÁߣǥÁØÃ¼Áß)/Ç¥ÁØÃ¼Áß¡¿100%·Î °è»êÇÑ´Ù. ºñ¸¸ÀÇ ¿øÀÎÀ¸·Î´Â À¯ÀüÀû ¿äÀÎ, ȯ°æÀû ¿äÀÎ, ¿¡³ÊÁö ´ë»çÀÇ ÀÌ»ó µîÀÌ ÀÖ´Ù. ºñ¸¸ÀÇ Á¾·ù¿¡´Â ¿øÀο¡ µû¶ó¼, ´Ü¼ø ºñ¸¸°ú ÁõÈļº ºñ¸¸À¸·Î ºÐ·ùÇÒ ¼ö ÀÖ´Ù. ´Ü¼ø ºñ¸¸Àº °ú½Ä°ú ¿îµ¿ ºÎÁ·ÀÌ ±× ¿øÀÎÀ̸ç, ÁõÈļº ºñ¸¸Àº ³»ºÐºñ, ½Ã»óÇϺμº, À¯Àü ¹× ´ë»ç¼º µîÀ¸·Î ¹ß»ýÇÑ´Ù. |
||
| ¿µ¹® | acetabular index | ÇÑ±Û | Àý±¸Áö¼ö, °ü°ñ±¸Áö¼ö |
|---|---|---|---|
| ¼³¸í | ¿ø·¡ Àý±¸´Â °ñ¹ÝÀÇ 3°³ÀÇ »À. Áï ¾ûµ¢»À, µÎµ¢»À, ±ÃµÕ»À·Î ¸¸µé¾îÁö´Â µ¥ ¼Ò¾Æ¿¡¼± ¾ÆÁ÷ ¿ÏÀüÇÑ »ÀµÇ±â°¡ ÀϾÁö ¾Ê¾Æ¼ ÀÌ ºÎºÐÀÌ »ï¹æ¿¬°ñÀý±¸·Î ¿¬°áµÇ¾î ÀÖ´Ù. ÀÌ »ï¹æ¿¬°ñÀ» ¿¬°áÇÑ ¼±°ú Àý±¸°¡Âʳ¡°ú »ï¹æ¿¬°ñÀÇ ¾ÈÂÊÀ» ¿¬°áÇÑ ¼±°úÀÇ °¢À» ¸»ÇÑ´Ù. ÀÌ °¢ÀÌ 40µµ ÀÌ»óÀ̸é Àý±¸ÀÇ ÀÌ»ó ¹ßÀ°À» ÀǹÌÇÑ´Ù. |
||
| CI | cardiac index; cardiac insufficiency; cell immunity; cell inhibition; cephalic index; cerebral infar... |
|---|---|
| MI | first meiotic metaphase; maturation index; medical illustrator; medical informatics; medical inspect... |
| PI | first meiotic prophase; isoelectric point; pacing impulse; package insert; pancreatic insufficiency;... |
| ISI | infarct size index; initial slope index; injury severity index; Institute for Scientific Information... |
| RI | radiation intensity; radioactive isotope; radioimmunology; recession index; recombinant inbred [stra... |
| DIO | Diet-induced obesity |
|---|---|
| OHS | Obesity Hypoventilation Syndrome |
| %OB | obesity |
| M/V INDEX | mitotic index |
| 2CDI | 2C deviation index |
| obesity index | Body weight divided by body volume. (05 Mar 2000) |
|---|
| anti-obesity agents | Agents that increase energy expenditure and weight loss by neural and chemical regulation. Beta-adrenergic agents and serotoninergic drugs have been experimentally used in patients with non-insulin dependent diabetes mellitus (niddm) to treat obesity. (12 Dec 1998) |
|---|---|
| central obesity | The deposition of obesity around the trunk sparing the limbs. (27 Sep 1997) |
| risks, obesity-related | Obesity increases the risk of developing a number of diseases including: type 2 (adult-onset) diabetes high blood pressure (hypertension) stroke (cerebrovascular accident or cva) heart attack (myocardial infarction or mi) heart failure (congestive heart failure) cancer (only certain forms such as prostate and colon cancer) gallstones and gall bladder disease (cholecystitis) gout and gouty arthritis osteoarthritis (degenerative arthritis) of the knees, hips, and the lower back sleep apnea (failure to breath normally during sleep, lowering blood oxygen) pickwickian syndrome (obesity, red face, underventilation, and drowsiness) (12 Dec 1998) |
| morbid obesity | Obesity sufficient to prevent normal activity or physiologic function, or to cause the onset of a pathologic condition. Simple obesity, obesity resulting when caloric intake exceeds energy expenditure. (05 Mar 2000) |
| hypothalamic obesity with hypogonadism | A disorder characterised primarily by obesity and hypogonadotrophic hypogonadism in adolescent boys; dwarfism is rare, and when present is thought to reflect hypothyroidism. Visual loss, behavioural abnormalities, and diabetes insipidus may occur. Frohlich's syndrome often is used synonymously for this disorder, although the original case involved a pituitary tumour; most cases are thought to result from hypothalamic dysfunction in areas regulating appetite and gonadal development. The most common causes are pituitary and hypothalamic neoplasms. Synonym: adiposis orchica, adiposogenital degeneration, adiposogenital dystrophy, adiposogenital syndrome, hypophysial syndrome, hypothalamic obesity with hypogonadism. Origin: L. Fr. G. Dys-, bad, + trophe, nourishment (05 Mar 2000) |
| diseases, obesity-related | Obesity increases the risk of developing a number of diseases including: Type 2 (adult-onset) diabetes High blood pressure (hypertension) Stroke (cerebrovascular accident or CVA) Heart attack (myocardial infarction or MI) Heart failure (congestive heart failure) Cancer (only certain forms such as prostate and colon cancer) Gallstones and gall bladder disease (cholecystitis) Gout and gouty arthritis Osteoarthritis (degenerative arthritis) of the knees, hips, and the lower back Sleep apnea (failure to breath normally during sleep, lowering blood oxygen) Pickwickian syndrome (obesity, red face, underventilation, and drowsiness). (12 Dec 1998) |
| obesity | <clinical sign> An increase in body weight beyond the limitation of skeletal and physical requirement, as the result of an excessive accumulation of fat in the body. Origin: L. Obesus = fat (18 Nov 1997) |
| obesity, morbid | The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. (12 Dec 1998) |
| obesity-related diseases | Obesity increases the risk of developing a number of diseases including: type 2 (adult-onset) diabetes high blood pressure (hypertension) stroke (cerebrovascular accident or cva) heart attack (myocardial infarction or mi) heart failure (congestive heart failure) cancer (only certain forms such as prostate and colon cancer) gallstones and gall bladder disease (cholecystitis) gout and gouty arthritis osteoarthritis (degenerative arthritis) of the knees, hips, and the lower back sleep apnea (failure to breath normally during sleep, lowering blood oxygen) pickwickian syndrome (obesity, red face, underventilation, and drowsiness). (12 Dec 1998) |
| absorbancy index | Absorbance (of light) per unit path length (usually the centimeter) and per unit of mass concentration. Compare: molar absorption coefficient. Synonym: absorbancy index, absorptivity, extinction coefficient, specific extinction. (05 Mar 2000) |
| alveolar index | Relation between the basialveolar (basion to alveolar point) and basinasal (basion to nasion) lengths: (basialveolar length × 100)/basinasal length; the result indicates the degree of projection of the maxilla or upper jaw. Synonym: alveolar index. (05 Mar 2000) |
| anaesthetic index | Ratio of the number of units of anaesthetic required for anaesthesia to the number of units of anaesthetic required to produce respiratory or cardiovascular failure. (05 Mar 2000) |
| antitryptic index | An obsolete term for the relative retardation in loss of viscosity of a solution of casein incubated with trypsin, to which a drop of abnormal blood serum (as from a cancerous patient) has been added, compared with that in a similar solution to which normal serum has been added; if the former drips through the tube of the viscosimeter in 100 seconds, and the latter in 104 seconds, the antitryptic index is 4. (05 Mar 2000) |
| Arneth index | An expression based on adding the percentages of polymorphonuclear neutrophils with 1 or 2 lobes in their nuclei, plus one-half the percentage with 3 lobes; the normal value is 60%. See: Arneth formula, Arneth count. (05 Mar 2000) |
| auricular index | Relation of the width to the height of the auricle or pinna: (width of pinna × 100)/length of pinna. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|